DRF
Sponsors
Biogen, University Hospital, Lille
Conditions
Relapsing Forms of Multiple SclerosisStroke
Phase 2
A Study to Learn About the Safety of BIIB091 and Its Effect on Brain Inflammation When Taken Alone or With Diroximel Fumarate (DRF) in Adults With Relapsing Forms of Multiple Sclerosis (MS)
CompletedNCT05798520
Start: 2023-07-25End: 2026-02-10Updated: 2026-02-20
DIROXIMEL FUMARATE TO REDUCE PERIHAEMATOMAL OEDEMA IN INTRACEREBRAL HAEMORRHAGE: DOUBLE BLIND RANDOMIZED CLINICAL TRIAL
Not yet recruitingNCT07275515
Start: 2026-02-01End: 2029-03-31Target: 192Updated: 2025-12-18